MOLECULAR-GENETICS OF THE DEBRISOQUIN-SPARTEINE POLYMORPHISM

被引：141

作者：

GONZALEZ, FJ ^{[1
]}

MEYER, UA ^{[1
]}

机构：

[1] UNIV BASEL,BIOCTR,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1991年 / 50卷 / 03期

关键词：

D O I：

10.1038/clpt.1991.131

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：233 / 238

页数：6

共 40 条

[1] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].

AYESH, R ;

IDLE, JR ;

RITCHIE, JC ;

CROTHERS, MJ ;

HETZEL, MR .

NATURE, 1984, 312 (5990) :169-170

[2]

BROLY F, IN PRESS DNA CELL BI

[3]

CAPORASO N, 1989, CANCER RES, V49, P3675

[4] LUNG-CANCER AND THE DEBRISOQUINE METABOLIC PHENOTYPE [J].

CAPORASO, NE ;

TUCKER, MA ;

HOOVER, RN ;

HAYES, RB ;

PICKLE, LW ;

ISSAQ, HJ ;

MUSCHIK, GM ;

GREENGALLO, L ;

BUIVYS, D ;

AISNER, S ;

RESAU, JH ;

TRUMP, BF ;

TOLLERUD, D ;

WESTON, A ;

HARRIS, CC .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (15) :1264-1272

[5]

DALY AK, IN PRESS MOL PHARM

[6]

DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057

[7] INTER-ETHNIC DIFFERENCE IN SPARTEINE OXIDATION AMONG GHANAIANS AND GERMANS [J].

EICHELBAUM, M ;

WOOLHOUSE, NM .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (01) :79-83

[8] CHROMOSOMAL ASSIGNMENT OF HUMAN CYTOCHROME-P-450 (DEBRISOQUINE SPARTEINE TYPE) TO CHROMOSOME 22 [J].

EICHELBAUM, M ;

BAUR, MP ;

DENGLER, HJ ;

OSIKOWSKAEVERS, BO ;

TIEVES, G ;

ZEKORN, C ;

RITTNER, C .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (04) :455-458

[9] THE GENETIC-POLYMORPHISM OF DEBRISOQUINE SPARTEINE METABOLISM - CLINICAL ASPECTS [J].

EICHELBAUM, M ;

GROSS, AS .

PHARMACOLOGY & THERAPEUTICS, 1990, 46 (03) :377-394

[10] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

← 1 2 3 4 →